An Open-label Pilot Study of Delayed Mycophenolate Mofetil Instead of Tacrolimus Combined With Anti-thymocyte Globulin, Daclizumab, Etanercept, and Sirolimus in Single-donor, Solitary Islet Allograft Recipients With Type 1 Diabetes.
Phase of Trial: Phase I/II
Latest Information Update: 01 Aug 2012
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Islet cell transplant rejection
- Focus Adverse reactions
- 28 Dec 2009 New trial record